Immunic names Michael Bonney as board chair
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors
May 19, 2026 6:30 AM EDTMore Than 30 Years of Leadership Experience Across Biopharmaceutical Commercialization
Played Key Role in the Launch and Commercial Success of Avonex® for Multiple Sclerosis
NEW YORK, May 19, 2026 /PRNewswire/ --Â Immunic, Inc. (Nasdaq:... More



